Antimicrobial-impregnated central venous catheters.
Schutze
Gordon E
GE
University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR, USA.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000494:pharmacology; D002405:Catheterization, Central Venous / Q000379:methods*; D002648:Child; D002710:Chlorhexidine / Q000008:administration & dosage / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D004867:Equipment Design; D006801:Humans; D008911:Minocycline / Q000008:administration & dosage / Q000494:pharmacology; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*; D012837:Silver Sulfadiazine / Q000008:administration & dosage / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D004791:Enzyme Inhibitors; D008911:Minocycline; D002710:Chlorhexidine; D012293:Rifampin; D012837:Silver Sulfadiazine